Ipamorelin raises growth hormone, but proof of a benefit in people is thin.

Ipamorelin in plain words

Made in a lab, Ipamorelin is a short peptide formed from five protein parts. This page covers its possible effects, weak proof, and safety gaps that may matter to you.

Ipamorelin tells the growth gland below the brain to release growth hormone. In animals, that rise did not raise two other hormones ^[1].

Cortisol helps the body handle stress, while prolactin helps women make breast milk. Keeping both near normal may avoid some unwanted effects seen with older drugs.

The best-known findings came from rats, pigs, and ferrets rather than patients. Researchers looked at bone, body weight, sleep, fat, and healing after hard work.

The only full trial in people tested slow bowels after surgery. Ipamorelin didn't help those patients and still isn't an approved medicine ^[3].

A small number after a study claim leads to the paper behind it. Personal accounts and unwanted effects appear on the effects page.

What Ipamorelin changed in animal studies

A 1998 animal study gave the strongest early finding. Ipamorelin raised growth hormone without raising two other hormones ^[1].

Those were cortisol, which helps manage stress, and prolactin, which helps make breast milk. An older peptide, named GHRP-6 in the paper, raised more of both.

Even at 200 times the needed amount, Ipamorelin left those hormones near normal ^[1]. The finding may mean fewer unwanted hormone effects, but only animals were tested.

Adult female rats also grew bone faster as the daily amount rose ^[4]. Untreated rats grew long bone at 42 micrometers per day.

A micrometer is one millionth of a meter. Growth rose to 44, 50, and 52 micrometers per day.

The rats received 18, 90, and 450 micrograms each day, in that order. A microgram is one millionth of a gram.

Researchers called one growth-related blood test IGF-1. The result did not change during the bone study.

The faster bone growth did not need a lasting rise in IGF-1. That result helps explain what changed in the rats and what did not.

A 2024 study gave ferrets 1 to 3 milligrams for each kilogram of body weight. The sick animals lost about 24% less weight, but their nausea didn't ease ^[5].

These tests show what happened to animals under set study conditions. They can't tell you whether your body would have the same changes or how those changes might affect your health.

What Ipamorelin has not proved in people

The Ipamorelin research page starts with the strongest animal findings. Rat bone grew faster, and sick ferrets kept more weight.

Some people say they slept better, healed faster after exercise, or looked leaner. No controlled human study has checked those personal accounts.

No trial has proved that Ipamorelin changes human fat or muscle. The only Phase 2 trial tested slow bowels after surgery and failed ^[3].

That stage is an early trial in patients that looks for benefit and harm. A separate study followed eight men after each amount was given ^[2].

That study showed how briefly the drug stayed in blood, not whether anyone improved. Claims about fat loss or muscle gain still rest on animal work.

For you, the gap between animal findings and human proof matters most. A sound idea about the body isn't the same as a shown benefit you can count on.

What the Ipamorelin papers can and cannot answer

A small number after a claim points to the paper that supports it. The Ipamorelin references page gives each paper and a public link.

The Ipamorelin effects page keeps personal accounts apart from study findings. It also names safety worries that come from growth hormone itself.

The research page puts the main papers in date order. The dose page says what each study gave and to whom.

Neither page turns a study amount into a plan for you. The weight and benefits pages also mark where animal facts end.

The FDA hasn't approved Ipamorelin for any use in people. The published research is real, but too small to answer the key health questions you may bring to your doctor.